Rythme cardiaque fœtal pendant le travail : définitions et interprétation

Martin, A.

doi:10.1016/j.jgyn.2007.11.009

Cited by 47 publications

(8 citation statements)

References 80 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The recorded variables are those shown in Table 2 . Fetal heart rate recordings were precisely reviewed and classified according to French guidelines (fetal tachycardia, bradycardia, decelerations, decreased variability) [ 29 ].…”

Section: Methodsmentioning

confidence: 99%

A Population-Based Study of Meconium Aspiration Syndrome in Neonates Born between 37 and 43 Weeks of Gestation

Fischer

Rybakowski

Ferdynus

et al. 2012

International Journal of Pediatrics

View full text Add to dashboard Cite

The epidemiology of meconium aspiration syndrome (MAS) in term neonates is described in a population-based retrospective study of data recorded for all births from 2000 to 2007 in a French region (Burgundy). Of the 132 884 eligible term newborns, the rate of meconium-stained amniotic fluid (MSAF) was 7.93%. The prevalence of severe MAS was 0.067% in the overall population. MAS rate was 0.11% at 37-38 weeks of gestation (WG), 0.20% at 39–41 WG, and 0.49% at 42-43 WG. Factors independently associated with severe MAS were identified by a case-control study, that is, thick meconium amniotic fluid, fetal tachycardia, Apgar score ≤3 at 1 minute, and birth in a level III facility. Our results confirm the high prevalence of MSAF after 37 WG but also show the low frequency of severe MAS in a period corresponding to the new international recommendations on the management of birth with MSAF.

show abstract

Section: Methodsmentioning

confidence: 99%

A Population-Based Study of Meconium Aspiration Syndrome in Neonates Born between 37 and 43 Weeks of Gestation

Fischer

Rybakowski

Ferdynus

et al. 2012

International Journal of Pediatrics

View full text Add to dashboard Cite

show abstract

“…Today, FHR monitoring remains the gold standard for intrapartum assessment of the fetus [115][116][117]. FHR monitoring is considered sensitive but not specific for detecting compromises in the health of the fetus.…”

Section: Existing Monitoring Technologiesmentioning

confidence: 99%

Fetal monitoring technologies for the detection of intrapartum hypoxia - challenges and opportunities

Hussain,

O’Halloran,

McDermott

et al. 2024

Biomed. Phys. Eng. Express

View full text Add to dashboard Cite

Intrapartum foetal hypoxia is related to long-term morbidity and mortality of the foetus and the mother. Foetal surveillance is extremely important to minimize the adverse outcomes arising from foetal hypoxia during labour. Several methods have been used in current clinical practice to monitor foetal well-being. For instance, biophysical technologies including cardiotocography, ST-analysis adjunct to cardiotocography, and Doppler ultrasound are used for intrapartum foetal monitoring. However, these technologies result in a high false-positive rate and increased obstetric interventions during labour. Alternatively, biochemical-based technologies including foetal scalp blood sampling and foetal pulse oximetry are used to identify metabolic acidosis and oxygen deprivation resulting from foetal hypoxia. These technologies neither improve clinical outcomes nor reduce unnecessary interventions during labour. Also, there is a need to link the physiological changes during foetal hypoxia to foetal monitoring technologies. The objective of this article is to assess the clinical background of foetal hypoxia and to review existing monitoring technologies for the detection and monitoring of foetal hypoxia. A comprehensive review has been made to predict foetal hypoxia using computational and machine-learning algorithms. The detection of more specific biomarkers or new sensing technologies is also reviewed which may help in the enhancement of the reliability of continuous foetal monitoring and may result in the accurate detection of intrapartum foetal hypoxia.

show abstract

“…Le glucose, principale source d'énergie cellulaire, est mis à disposition grâce à l'induction de la glycogénolyse hépatique par la stimulation du système sympathique par l'hypoxie [7]. L'adrénaline et la noradrénaline circulantes sécrétées par la médullosurrénale agissent au niveau du foie pour augmenter la quantité de glucose disponible dans le sang, permettant de maintenir la production d'ATP qui est largement altérée par le passage en métabolisme anaérobie [8].…”

Section: Adaptation Du Métabolisme éNergiqueunclassified

“…Le but est d'aider le clinicien à interpréter les variations du RCF, observées au cours du travail. Nous n'exposerons pas ici les caractéristiques du RCF qui ont été parfaitement décrites dans une précédente revue [7].…”

Section: Introductionunclassified